← Leaderboards
Adam D Bachstetter
University Of Kentucky
$7,223,838
Attributed
$11,768,777
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,768,777 · 12
By mechanism
R01$7,902,312 · 4
R21$1,685,750 · 4
RF1$1,147,500 · 1
R00$732,126 · 1
K99$175,102 · 1
F32$125,987 · 1
Top collaborators
- Michael Paul Murphy8 shared
- Marilyn J. Duncan6 shared
- Bruce Frederick O'Hara6 shared
- Sridhar Sunderam6 shared
- Christopher Mark Norris4 shared
- John C Gensel2 shared
- Mark Anthony Lovell1 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Peter T Nelson$21,085,191
- Christopher Mark Norris$15,768,108
- Mark Anthony Lovell$4,992,096
- Maj-Linda B Selenica$1,817,146
- Michael Paul Murphy$8,590,720
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMouse ModelBrainNeuroinflammationS DiseaseInflammationChronicResponseSynapsesNeurodegenerative DisordersMicrogliaPathway InteractionsInflammatoryPathologyMediatingTraumatic Brain InjuryNerve DegenerationInjuryExhibitsPathologicClosed Head InjuriesPharmaceutical PreparationsGeneticKnockout Mice
Grant awards (32)
Neuronal IL-1R1 Signaling in Mild Closed Head Injury$418,876
R01 · FY2025 · NS · contact PI
Translational Approaches to Mitigate Enhanced Alzheimerâs Disease Risk Following a Mild TBI$344,250
R01 · FY2025 · NS · contact PI
Sleep Fragmentation and Alzheimerâs Disease$717,087
R01 · FY2024 · AG
Therapeutic Value of BNC-1 in Addressing Tau Pathology in TBI$423,500
R21 · FY2024 · AG · contact PI
Neuronal IL-1R1 Signaling in Mild Closed Head Injury$406,308
R01 · FY2024 · NS · contact PI
Translational Approaches to Mitigate Enhanced Alzheimerâs Disease Risk Following a Mild TBI$382,500
R01 · FY2024 · NS · contact PI
Drug repurposing for Alzheimerâs disease-related inflammation caused by a TBI$191,250
R21 · FY2024 · AG · contact PI
Sleep Fragmentation and Alzheimerâs Disease$729,327
R01 · FY2023 · AG
Neuronal IL-1R1 Signaling in Mild Closed Head Injury$429,134
R01 · FY2023 · NS · contact PI
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury$326,976
R01 · FY2023 · NS · contact PI
Drug repurposing for Alzheimerâs disease-related inflammation caused by a TBI$229,500
R21 · FY2023 · AG · contact PI
Sleep Fragmentation and Alzheimerâs Disease$741,567
R01 · FY2022 · AG
Neuronal IL-1R1 Signaling in Mild Closed Head Injury$442,384
R01 · FY2022 · NS · contact PI
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury$327,204
R01 · FY2022 · NS · contact PI
Administrative Supplement to Sleep Fragmentation and Alzheimer's Disease$153,000
R01 · FY2022 · AG
Translational Approaches to Mitigate Enhanced Alzheimerâs Disease Risk Following a Mild TBI$1,147,500
RF1 · FY2021 · NS · contact PI
Sleep Fragmentation and Alzheimerâs Disease$752,277
R01 · FY2021 · AG
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury$327,496
R01 · FY2021 · NS · contact PI
Sleep Fragmentation and Alzheimerâs Disease$736,852
R01 · FY2020 · AG
Pumping iron: Loss of iron homeostasis causes microglia degeneration in AD$420,750
R21 · FY2020 · AG · contact PI
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury$333,480
R01 · FY2020 · NS · contact PI
SLC9A1 and Neurodegenerative Disease$191,250
R21 · FY2020 · AG
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain Injury$333,594
R01 · FY2019 · NS · contact PI
SLC9A1 and Neurodegenerative Disease$229,500
R21 · FY2019 · AG
Involvement of myelin integrity in Alzheimer's disease pathogenesis$238,741
R00 · FY2018 · AG · contact PI
Involvement of myelin integrity in Alzheimer's disease pathogenesis$244,385
R00 · FY2017 · AG · contact PI
Involvement of myelin integrity in Alzheimer's disease pathogenesis$249,000
R00 · FY2016 · AG · contact PI
Involvement of myelin integrity in Alzheimer's disease pathogenesis$85,661
K99 · FY2015 · AG · contact PI
Involvement of myelin integrity in Alzheimer's disease pathogenesis$89,441
K99 · FY2014 · AG · contact PI
Harnessing microglia towards repair vs. damage: Does p38 MAPK hold the reins?$27,055
F32 · FY2012 · AG · contact PI
Harnessing microglia towards repair vs. damage: Does p38 MAPK hold the reins?$51,326
F32 · FY2011 · AG · contact PI
Harnessing microglia towards repair vs. damage: Does p38 MAPK hold the reins?$47,606
F32 · FY2010 · AG · contact PI